Details for New Drug Application (NDA): 210799
✉ Email this page to a colleague
NDA 210799 describes DIAZOXIDE, which is a drug marketed by Abraxis Pharm, E5 Pharma Inc, and Novitium Pharma, and is included in three NDAs. It is available from two suppliers. Additional details are available on the DIAZOXIDE profile page.
The generic ingredient in DIAZOXIDE is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
The generic ingredient in DIAZOXIDE is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
Summary for 210799
| Tradename: | DIAZOXIDE |
| Applicant: | Novitium Pharma |
| Ingredient: | diazoxide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 210799
Suppliers and Packaging for NDA: 210799
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIAZOXIDE | diazoxide | SUSPENSION;ORAL | 210799 | ANDA | Endo USA, Inc. | 0254-1010 | 0254-1010-19 | 1 BOTTLE, DROPPER in 1 CARTON (0254-1010-19) / 30 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 50MG/ML | ||||
| Approval Date: | Jul 8, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
